Beyond daily injections: Implementing once weekly basal insulin to simplify and personalize care

Beyond daily injections: Implementing once-weekly basal insulin to simplify and personalize care is designed for us-based endocrinologists and endocrinology-focused NPs and PAs in the management of patients with Type 2 Diabetes (T2D). Once-weekly basal insulin regimens are poised to enter the treatment armamentarium for diabetes management. Gaps in understanding the unique molecular design and pharmacology of, and latest clinical data on these novel formulations may contribute to therapeutic inertia and delayed implementation of a more convenient, flexible, and potentially safer alternative to daily insulin regimens for patients with T2D.